Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biological Age”

350 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 350 results

Not applicableStudy completedNCT01348581
What this trial is testing

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Who this might be right for
Pressure UlcersVenous UlcersDiabetic Ulcers+2 more
Kerecis Ltd. 37
Large-scale testing (Phase 3)Study completedNCT00456807
What this trial is testing

Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 100
Large-scale testing (Phase 3)Study completedNCT00306241
What this trial is testing

Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Study completedNCT00356369
What this trial is testing

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Large-scale testing (Phase 3)Study completedNCT00345878
What this trial is testing

Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 271
Large-scale testing (Phase 3)Study completedNCT01884519
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 120
Testing effectiveness (Phase 2)Study completedNCT03204227
What this trial is testing

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 220
Not applicableLooking for participantsNCT07064395
What this trial is testing

Bright Light Therapy on Sleep Health in Lung Cancer Patients

Who this might be right for
Lung Cancers
Henry Ford Health System 20
Not applicableWithdrawnNCT03734419
What this trial is testing

The Use of Aging Biomarkers in Saliva, Based on DNA Methylation Status in Elovl2 to Predict Biological Age

Who this might be right for
Healthy
HKGepitherapeutics
Testing effectiveness (Phase 2)Study completedNCT00532298
What this trial is testing

Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over

Who this might be right for
Influenza
GlaxoSmithKline 1,596
Not applicableStudy completedNCT00500617
What this trial is testing

Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree

Who this might be right for
Coronary Artery DiseaseAngina PectorisChest Pain+5 more
CardioDx 4,350
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Post-approval studies (Phase 4)Study completedNCT03083158
What this trial is testing

Immunity to Hepatitis B Vaccine

Who this might be right for
Hepatitis BImmunization; Infection
University of British Columbia 16
Large-scale testing (Phase 3)Study completedNCT01878825
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 121
Not applicableActive Not RecruitingNCT05778032
What this trial is testing

Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS)

Who this might be right for
Prader-Willi Syndrome
Istituto Auxologico Italiano 30
Large-scale testing (Phase 3)Study completedNCT01711736
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 606
Testing effectiveness (Phase 2)Study completedNCT01416571
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 78
Large-scale testing (Phase 3)Study completedNCT00485732
What this trial is testing

Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 225
Early research (Phase 1)Study completedNCT00197067
What this trial is testing

Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.

Who this might be right for
Malaria
GlaxoSmithKline 200
Testing effectiveness (Phase 2)Study completedNCT00360230
What this trial is testing

Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children

Who this might be right for
Malaria
GlaxoSmithKline 540
Load More Results